A more advanced T1DM model would introduce cofounding effects relating to nephropathy, such as renin–angiotensin–aldosterone system (RAAS) activation, and would not easily provide insight into the mechanism unpinning any changes to PN. The gene discussed is REN; the disease is kidney disorder.